Midwest Center of Excellence for Vector-Borne Diseases (MCE-VBD)
Official title: CK22-005, The Midwest Center of Excellence for Vector-Borne Disease
Funded at University of Wisconsin-Madison · NIH-11509990 · Data updated 2026-11-12
A regional effort to reduce infections from mosquitoes and ticks by improving prevention, control methods, and public education in the Midwest.
Quick facts
| Grant type | U01 cooperative agreement |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project start | July 1, 2022 |
| Project end | June 30, 2027 |
| Funding year | 2026 |
| Award (this year) | $1,999,240 |
| NIH project number | 5U01CK000651-05 |
| Project ID | NIH-11509990 on NIH RePORTER |
Who could benefit from this research
✓Could help
Not applicable to individual patients; the research informs public health prevention and control of vector-borne diseases.
✕Less likely to help
Direct patient-level benefits may be limited to those receiving downstream prevention resources and community education.
What this research studies
This program brings together universities, public health agencies, and vector-control groups across six Midwest states to address how climate change alters the risk of vector-borne diseases. It aims to test and develop better ways to prevent human bites and disease transmission, using data-driven tools and outreach to communities. Researchers will study current control methods, create new prevention tools, and translate findings into practical resources for public health and mosquito/tick control programs.
Why it matters
Potential benefit: If successful, communities could see fewer vector-borne infections and quicker adoption of better prevention strategies.
How similar studies have gone: Previous vector-borne disease programs have improved prevention when strong regional collaboration and rapid translation of findings are in place.
Where this research is happening
-
University of Wisconsin-Madison
Madison, United States Active
Researchers
- Principal investigator: Paskewitz, Susan M — University of Wisconsin-Madison
- Study coordinator: Paskewitz, Susan M
Related research
Other NIH-funded projects on the same topics.
-
BRAVE Innovation Center for Viral Resistance in Chickens
A center at UW–Madison aims to create chickens genetically resistant to avian viruses like H5N1 by identifying host genes involved in virus replication using genome-wide CRISPR screening.
-
Center to Fight Vector-Borne Diseases in the Midwest
A Midwest program brings researchers, public health teams, and vector-control groups together to prevent diseases spread by ticks and mosquitoes.
-
Globally useful predictor for cervical cancer treatment response
This project aims to develop a simple predictive signature to personalize treatment for locally advanced cervical cancer using easy tests and imaging.
-
Neutrophil development with stem cells to understand their behavior
Researchers are studying how neutrophils, a type of immune cell, develop from stem cells to better understand why they can help or harm in infections and inflammatory diseases.
-
WREN: Expanding Research Capacity in Rural Primary Care Clinics
A nationwide network in Wisconsin will strengthen rural primary care clinics to participate in real-world research and bring more clinical trials to communities.
-
Targeting early oral GVHD to improve mouth health after stem cell transplant
A study at UW–Madison will explore why some transplant patients develop painful oral GVHD and test ideas to prevent and lessen mouth-related problems.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.